Flagship Biosciences, Inc. — Form D

Flagship Biosciences, Inc. of BROOMFIELD, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-18. The offering totals $6.4M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Herb HooperDirectorBroomfield, CO
Trevor JohnsonDirectorBroomfield, CO
Paul KirchgraberDirectorBroomfield, CO
William SniderDirectorBethesda, MD
Tom TuriDirectorBroomfield, CO
Trevor JohnsonExecutive OfficerBroomfield, CO
Tom TuriExecutive OfficerBroomfield, CO
Trevor JohnsonPromoterBroomfield, CO
Bill H SniderDirectorBroomfield, CO
Fisher AaronDirectorBroomfield, CO
Herb H HooperDirectorBroomfield, CO
Tom H TuriDirectorBroomfield, CO
Joe Dean KrugerExecutive OfficerWestminster, CO
Nancy Dean GillettDirectorWestminster, CO
G. David YoungDirectorWestminster, CO
G. David YoungExecutive OfficerWestminster, CO
G. David YoungPromoterWestminster, CO
Gary Dean ClarkDirectorWestminster, CO
L. Dean NortheyExecutive OfficerWestminster, CO
Holger Dean LangeExecutive OfficerWestminster, CO
Dean David NortheyExecutive OfficerWestminster, CO
Nancy A GillettDirectorWestminster, CO
Gary M ClarkDirectorWestminster, CO
Gregory K TuckerDirectorWestminster, CO

Other filings by this issuer (5)

FiledFormOfferingSold
2024-02-21D/A$5.0M$3.0M
2023-12-14D$1.5M$1.5M
2022-09-09D$15.3M$15.3M
2018-07-09D$2.5M$2.5M
2018-03-16D$1.0M$1.0M

More